Accelerate Diagnostics Share Holder Equity 2010-2024 | AXDX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Accelerate Diagnostics share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Accelerate Diagnostics share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$212.6B
Intuitive Surgical (ISRG)	$186.7B
Alcon (ALC)	$45.7B
IQVIA Holdings (IQV)	$39.5B
Edwards Lifesciences (EW)	$38.8B
IDEXX Laboratories (IDXX)	$35.5B
DexCom (DXCM)	$26.9B
Waters (WAT)	$22.9B
SONOVA HOLDING (SONVY)	$22B
STERIS (STE)	$21.3B
Hologic (HOLX)	$18.4B
Fresenius Medical Care AG KGaA (FMS)	$12.5B
Sysmex ADR (SSMXY)	$12.4B
Globus Medical (GMED)	$11.1B
Teleflex (TFX)	$9.2B
Penumbra (PEN)	$8.9B
Masimo (MASI)	$8.6B
Glaukos (GKOS)	$7.7B
PROCEPT BioRobotics (PRCT)	$5B
Integer Holdings (ITGR)	$4.5B
Inari Medical (NARI)	$3B
TransMedics (TMDX)	$2.9B
Veracyte (VCYT)	$2.9B
LivaNova (LIVN)	$2.8B
Nihon Kohden (NHNKY)	$2.5B
Elekta AB (EKTAY)	$2.3B
Tandem Diabetes Care (TNDM)	$2.2B
Integra LifeSciences Holdings (IART)	$2B
RxSight (RXST)	$1.9B
Alphatec Holdings (ATEC)	$1.3B